Outset Medical, Inc. (NASDAQ:OM) CFO Sells $27,430.40 in Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 34,288 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $27,430.40. Following the sale, the chief financial officer now owns 258,869 shares in the company, valued at $207,095.20. The trade was a 11.70 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Nabeel Ahmed also recently made the following trade(s):

• On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $23,515.11.
• On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total transaction of $2,367.15.
• On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total transaction of $3,376.80.

Outset Medical Trading Down 1.1 %

NASDAQ:OM opened at $0.85 on Friday. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The business has a fifty day moving average of $1.01 and a 200-day moving average of $1.26.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 target price on shares of Outset Medical in a research report on Tuesday, January 7th.

Hedge Funds Weigh In On Outset Medical

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. National Bank of Canada FI increased its position in shares of Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares during the period. Huntington National Bank grew its holdings in Outset Medical by 46.2% during the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after acquiring an additional 20,000 shares during the period. GSA Capital Partners LLP raised its position in Outset Medical by 924.7% in the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock worth $753,000 after acquiring an additional 1,003,135 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Outset Medical in the 2nd quarter valued at about $259,000. Finally, Point72 Asset Management L.P. bought a new position in shares of Outset Medical during the 2nd quarter valued at about $827,000.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.